CLINICAL TRIALS PROFILE FOR LULICONAZOLE
✉ Email this page to a colleague
All Clinical Trials for LULICONAZOLE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00869336 ↗ | Multicenter Study of the Efficacy and Safety of Luliconazole Cream in Tinea Pedis (Athlete's Foot) | Completed | Tinea Pharmaceuticals | Phase 2 | 2009-03-01 | To examine the safety and optimal duration of Luliconazole Cream 1% treatments for 14 days or 28 days to achieve "complete clearance" at 2 weeks post treatment. |
NCT01044381 ↗ | Open-Label Pharmacokinetics (PK)/Safety Study of Luliconazole Solution, 10% in Distal Subungual Onychomycosis | Completed | Topica Pharmaceuticals | Phase 1/Phase 2 | 2010-12-01 | To determine the safety, tolerability, systemic exposure and pharmacokinetics of luliconazole after repeat daily topical application of Luliconazole Solution, 10% in a maximal use setting in adults with distal subungual onychomycosis of the toenails. |
NCT01431820 ↗ | Safety and Efficacy of Luliconazole Solution, 10% in Subjects With Mild to Moderate Onychomycosis | Completed | Topica Pharmaceuticals | Phase 2/Phase 3 | 2012-05-01 | The purpose of this study is to determine the safety and efficacy of a topical antifungal formulation, Luliconazole Solution, 10%, in the treatment of adults with onychomycosis of the toenails. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for LULICONAZOLE
Condition Name
Clinical Trial Locations for LULICONAZOLE
Trials by Country
Clinical Trial Progress for LULICONAZOLE
Clinical Trial Phase
Clinical Trial Sponsors for LULICONAZOLE
Sponsor Name